NCT07877207Not yet recruiting
AI-Supported CBT-Based Psychoeducation for Caregivers of Individuals With Schizophrenia
Development of an Artificial Intelligence-Supported, Cognitive Behavioral Approach-Based Psychoeducation Program for Caregivers of Individuals Diagnosed With Schizophrenia and Evaluation of Its Effects on Caregiver Burden and Emotional Expressivity
Source: ClinicalTrials.gov · Last updated 16 Oct 2026
Brief summary (registry, in English)
Schizophrenia is a chronic mental disorder that affects the diagnosed individual and the family members involved in the care process from a biopsychosocial perspective. The course of the illness, the recurrence of symptoms, and the high level of care required can increase the burden on caregivers and make it difficult for them to express their emotions. Structured psychoeducation and cognitive-behavioral interventions have been reported to be beneficial for caregivers in managing these challenges. The aim of this study is to develop an AI-supported psychoeducation program based on a cognitive-behavioral approach for caregivers of individuals diagnosed with schizophrenia and to evaluate the program's impact on caregiving burden and the level of emotional expression. The six-week program will cover topics such as the caregiver role and burden, schizophrenia, the thought-emotion-behavior cycle, recognizing and expressing emotions, effective communication, setting boundaries, seeking support, signs of relapse, and crisis planning. Content based on scientific literature will be evaluated by experts. Artificial intelligence will facilitate interaction with the content, participation in activities, the application of skills, and structured feedback. The system will not provide clinical assessments, diagnoses, or personalized treatment recommendations; participants will be referred to appropriate healthcare services in situations requiring professional evaluation. The study will be conducted using a quasi-experimental design with pre-test and post-test control groups. A total of 88 caregivers will be recruited, with 44 assigned to the experimental group and 44 to the control group. The program will be administered to the experimental group, while the control group will receive routine care. Data will be collected using the Caregiver Descriptive Information Form, the Zarit Caregiver Burden Scale, and the Emotional Expression Scale. A Program Evaluation Form will also be used for the experimental group. The program to be developed is expected to reduce the caregiving burden on caregivers and improve their ability to express emotions. It is anticipated that the findings will contribute to psychiatric nursing practice, the development of AI-supported psychoeducation programs, and the strengthening of psychosocial support provided to caregivers.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 88 (estimated)
- First submitted
- 28 Aug 2026
- Start date
- 20 Oct 2026
- Primary completion date
- 15 Dec 2026
- Lead sponsor
- Kastamonu University
- Diseases
- Schizophrenia
- NCT number
- NCT07877207
What you commit to
- Study type: Interventional
- Planned participants: 88
- From 20 Oct 2026 to the primary completion date, 15 Dec 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Presence of a psychotic disorder, severe depression, an active episode of bipolar disorder, or cognitive impairment that would prevent participation in the study.
- Experiencing an acute psychiatric crisis, intense grief, or severe emotional distress that would interfere with study participation.
Other
- Inability to read and write, communicate in Turkish, understand the study questionnaires, or provide valid responses.
- The schizophrenia diagnosis of the care recipient has not been confirmed, is still under evaluation, or is not documented in the healthcare institution's medical records.
- Lack of access to an internet-connected digital device.
- \-
Who the study is looking for
- Aged 18 years or older. Able to read and write, communicate in Turkish, and possess sufficient cognitive ability to understand and complete the study questionnaires.
- A family member and primary caregiver of an individual who is being followed at a healthcare institution with a diagnosis of schizophrenia.
- Providing care to the individual diagnosed with schizophrenia for at least six months.
- The schizophrenia diagnosis of the care recipient is documented in the healthcare institution's medical records.
- Having access to an internet-connected digital device, such as a smartphone, tablet, or computer.
- Willing to participate in the artificial intelligence-supported psychoeducation program if assigned to the intervention group.
- Voluntarily agreeing to participate and providing written informed consent.
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.